Search Results - "Forgeson, Garry"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Neoadjuvant chemotherapy in non‐metastatic breast cancer: a study on practice trends in a regional cancer treatment service by Ang, Edmond, Wewala, Navin, Carroll, Rebecca, Forgeson, Garry, Anderson, Malcolm, Fernando, Jennifer, Jordan, Jody, Isaacs, Richard

    Published in Internal medicine journal (01-03-2020)
    “…Background Neoadjuvant chemotherapy (NACT) is increasingly used for managing locally advanced and high risk non‐metastatic breast cancer. Aims To describe…”
    Get full text
    Journal Article
  3. 3

    A prospective audit on use of prophylactic antiemetics and rates of CINV in patients receiving carboplatin AUC≥4 or combination anthracycline/cyclophosphamide by Lo, Edward

    Published in New Zealand medical journal (16-04-2021)
    “…Assesses current use of prophylactic antiemetics and rates of chemotherapy-induced nausea and vomiting (CINV) in patients under the care of MidCentral Regional…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Bleeding from gastrointestinal tract recurrence of non-seminomatous germ cell tumour testis, showing temporary response to gemcitabine and oxaliplatin chemotherapy by Prince, Stephanie K, Forgeson, Garry

    Published in New Zealand medical journal (01-11-2013)
    “…Contributes the first reported case of gemcitabine/oxaliplatin (GemOx) chemotherapy used for recurrent non-seminomatous germ cell tumour of the testis…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A workforce survey of New Zealand medical oncologists by Bidwell, Simon

    Published in New Zealand medical journal (15-03-2013)
    “…Presents the findings of a Medical Oncology Work Group (MOWG) survey of vocationally registered medical oncologists regarding workload and other issues…”
    Get full text
    Journal Article
  9. 9

    The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre by Chrystal, Kathryn

    Published in New Zealand medical journal (24-01-2003)
    “…Studies the prevalence and patterns of complementary/alternative medicine (CAM) use in cancer patients managed by a NZ regional cancer treatment centre…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Bleeding from gastrointestinal tract recurrence of non-seminomatous germ cell tumour testis, showing temporary response to gemcitabine and oxaliplatin chemotherapy by Prince, Stephanie K, Forgeson, Garry

    Published in New Zealand medical journal (01-11-2013)
    “…The first reported case of gemcitabine/oxaliplatin (GemOx) chemotherapy used for recurrent non-seminomatous germ cell tumour of the testis metastatic to the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Seek and ye shall find : Hodgkin's lymphoma presenting as paraneoplastic cerebellar degeneration by Tie, Jeanne

    Published in New Zealand medical journal (13-04-2007)
    “…Presents the case of a patient who developed a rapidly progressive cerebellar ataxia and underwent extensive investigations before a paraneoplastic aetiology…”
    Get full text
    Journal Article
  14. 14

    Seek and ye shall find: Hodgkin's lymphoma presenting as paraneoplastic cerebellar degeneration by Tie, Jeanne, Forgeson, Garry, McNabb, Andrew, Roebert, Justin

    Published in New Zealand medical journal (13-04-2007)
    “…Paraneoplastic neurological syndromes (PNS) are rare complications of cancer and may be the presenting sign of an occult malignancy. Diagnosis of PNS is often…”
    Get full text
    Journal Article
  15. 15

    The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre by Chrystal, Kathryn, Allan, Simon, Forgeson, Garry, Isaacs, Richard

    Published in New Zealand medical journal (24-01-2003)
    “…To study the prevalence and patterns of complementary/alternative medicine (CAM) use in cancer patients managed by a New Zealand regional cancer treatment…”
    Get full text
    Journal Article
  16. 16

    Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide by Gore, M, Powles, R, Lakhani, A, Milan, S, Maitland, J, Goss, G, Nandi, A, Perren, T, Forgeson, G, Treleaven, J

    Published in Cancer chemotherapy and pharmacology (01-01-1989)
    “…A total of 65 patients under the age of 55 with acute leukaemia received high-dose cytosine arabinoside (Ara-C) in combination with high-dose etoposide without…”
    Get full text
    Journal Article